טוען...
Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide on Research Studies in the United States
PURPOSE: Novel agents are currently combined with radiation and temozolomide (RT+TMZ) in newly diagnosed glioblastoma using overall survival as the primary endpoint. Results of these phase II studies are typically compared to the phase III EORTC survival data that resulted in RT+TMZ becoming standar...
שמור ב:
| Main Authors: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2010
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2861898/ https://ncbi.nlm.nih.gov/pubmed/20371685 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-3106 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|